興寶膠囊
A research perspective on liver health. Maxluck's 興寶膠囊 (LIVERCHRON CAPS) is a Nutrition Selections 2026 Best Hepatic Guard Award recipient. Explore its academic collaboration background and the research focus on lipid metabolism.
A development story shaped by academic collaboration
興寶膠囊 is a capsule-format health supplement from Taiwan's Maxluck. According to the supplied document, Maxluck Biotech Corp. undertook development through collaboration with National Chung Hsing University, with related research-project support from Taiwan's then National Science Council and Ministry of Economic Affairs.
Exploring liver health through research into nutrition and biological processes forms the background to the product's development.
A broader view of the liver, centered on lipid metabolism
The research material examines the relationship between liver fat accumulation, lipid metabolism, oxidative stress and inflammation. Its scope extends beyond the amount of fat to factors involved in metabolism and responses within tissue.
Looking at the liver from these multiple perspectives is a theme running throughout the document.
The study setting: eight weeks in mice
Figures 1–5 report an animal experiment involving daily supplementation for eight weeks in mice fed a high-fat diet. This was not a human clinical trial measuring the effects of taking the product.
The document labels the experimental group LiverChrom and presents differences relative to a comparison group. Multiple measures, from lipid metabolism to oxidative and inflammatory responses, were observed within the same experiment.
Two observations related to lipid metabolism
In the mouse experiment, the document reports higher expression of PPAR-α, which is involved in lipid metabolism, and lower triglyceride content in liver tissue relative to the comparison group.
Observing both a lipid-metabolism-related factor and the amount of lipid in tissue is a central point in understanding the research material for 興寶膠囊.
Extending the research view to oxidative stress and inflammation
The same mouse experiment also reports lower serum ALT and AST, lower MDA, an oxidative-damage-related marker, and lower expression of CD68, presented as an inflammation-related marker, relative to the comparison group. Alongside fat accumulation, the research examined responses associated with liver injury, oxidative processes and inflammation.
Product introduction at the time of the award (supplied materials)
This description is based on supplied product materials. It is not a verification of efficacy or performance by this award. Please contact the supplier for current specifications and labeling.
English is a reference translation of the Japanese product introduction. The original award name and year are unchanged.
